353 related articles for article (PubMed ID: 27581129)
1. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Hackmann K; Kuhlee F; Betcheva-Krajcir E; Kahlert AK; Mackenroth L; Klink B; Di Donato N; Tzschach A; Kast K; Wimberger P; Schrock E; Rump A
Breast Cancer Res Treat; 2016 Oct; 159(3):585-90. PubMed ID: 27581129
[TBL] [Abstract][Full Text] [Related]
2. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM
BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479
[TBL] [Abstract][Full Text] [Related]
3. Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Pelttari LM; Shimelis H; Toiminen H; Kvist A; Törngren T; Borg Å; Blomqvist C; Bützow R; Couch F; Aittomäki K; Nevanlinna H
Clin Genet; 2018 Mar; 93(3):595-602. PubMed ID: 28802053
[TBL] [Abstract][Full Text] [Related]
4.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
6. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
7. Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.
Rizza R; Hackmann K; Paris I; Minucci A; De Leo R; Schrock E; Urbani A; Capoluongo E; Gelli G; Concolino P
Mol Diagn Ther; 2019 Feb; 23(1):121-126. PubMed ID: 30506513
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
[TBL] [Abstract][Full Text] [Related]
9. A tandem duplication of BRCA1 exons 1-19 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome.
Du C; Mark D; Wappenschmidt B; Böckmann B; Pabst B; Chan S; Cao H; Morlot S; Scholz C; Auber B; Rhiem K; Schmutzler R; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res Treat; 2018 Dec; 172(3):561-569. PubMed ID: 30191368
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.
Byers H; Wallis Y; van Veen EM; Lalloo F; Reay K; Smith P; Wallace AJ; Bowers N; Newman WG; Evans DG
Eur J Hum Genet; 2016 Nov; 24(11):1591-1597. PubMed ID: 27273131
[TBL] [Abstract][Full Text] [Related]
11. Fast Detection of a BRCA2 Large Genomic Duplication by Next Generation Sequencing as a Single Procedure: A Case Report.
Nunziato M; Starnone F; Lombardo B; Pensabene M; Condello C; Verdesca F; Carlomagno C; De Placido S; Pastore L; Salvatore F; D'Argenio V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165356
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.
Hayes JL; Tzika A; Thygesen H; Berri S; Wood HM; Hewitt S; Pendlebury M; Coates A; Willoughby L; Watson CM; Rabbitts P; Roberts P; Taylor GR
Genomics; 2013 Sep; 102(3):174-81. PubMed ID: 23598253
[TBL] [Abstract][Full Text] [Related]
13. [Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing].
Minucci A; Mazzuccato G; Marchetti C; Pietragalla A; Scambia G; Fagotti A; Urbani A
Mol Biol (Mosk); 2020; 54(4):688-698. PubMed ID: 32840490
[TBL] [Abstract][Full Text] [Related]
14. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
15. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
[TBL] [Abstract][Full Text] [Related]
16. The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.
Schubert S; van Luttikhuizen JL; Auber B; Schmidt G; Hofmann W; Penkert J; Davenport CF; Hille-Betz U; Wendeburg L; Bublitz J; Tauscher M; Hackmann K; Schröck E; Scholz C; Wallaschek H; Schlegelberger B; Illig T; Steinemann D
Int J Cancer; 2019 Jun; 144(11):2683-2694. PubMed ID: 30426508
[TBL] [Abstract][Full Text] [Related]
17. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome.
Concolino P; Rizza R; Hackmann K; Minucci A; Scaglione GL; De Bonis M; Costella A; Zuppi C; Schrock E; Capoluongo E
Mol Diagn Ther; 2017 Oct; 21(5):539-545. PubMed ID: 28620890
[TBL] [Abstract][Full Text] [Related]
19. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
[TBL] [Abstract][Full Text] [Related]
20. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.
Vasickova P; Machackova E; Lukesova M; Damborsky J; Horky O; Pavlu H; Kuklova J; Kosinova V; Navratilova M; Foretova L
BMC Med Genet; 2007 Jun; 8():32. PubMed ID: 17561994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
